Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes

P. Hrubá, I. Brabcová, F. Gueler, Z. Krejčík, V. Stránecký, E. Svobodová, J. Malušková, W. Gwinner, E. Honsová, A. Lodererová, R. Oberbauer, R. Zachoval, O. Viklický,

. 2015 ; 88 (4) : 785-795. [pub] 20150715

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie, práce podpořená grantem, validační studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc16028367

Grantová podpora
NT11227 MZ0 CEP - Centrální evidence projektů
NT14102 MZ0 CEP - Centrální evidence projektů

The significance of borderline changes in kidney allograft biopsies is widely debated. To help resolve this, we studied differences in intrarenal gene expression patterns between early clinical and 3-month protocol biopsies, all of which had borderline histologic changes. The gene expression profiles in training set of patients by microarray analysis and data were validated in a larger cohort using RT-qPCR. There was greater expression of immunity- and inflammation-related genes in the early clinical biopsies compared to the 3-month protocol biopsies with borderline changes. In early clinically manifested borderline changes, graft deterioration within 24 months due to chronic rejection was associated with increased activation of immune, defense, and inflammatory processes. Regression modeling identified higher donor age and expression of macrophage receptor CLEC5A as risk factors for progression. In the 3-month protocol biopsies with borderline changes, graft dysfunction was associated with increased expression of fibrinogen complex transcripts. The discrimination power of fibrinogen was confirmed by cross-validation on two independent cohorts. Thus, our study highlights variations in gene expression between clinical and subclinical borderline changes despite similar histological findings. The data also support a recommendation for frequent patient monitoring, especially in those with borderline changes who received grafts from older donors.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16028367
003      
CZ-PrNML
005      
20191118101205.0
007      
ta
008      
161005s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/ki.2015.211 $2 doi
024    7_
$a 10.1038/ki.2015.211 $2 doi
035    __
$a (PubMed)26176825
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hrubá, Petra $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
245    10
$a Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes / $c P. Hrubá, I. Brabcová, F. Gueler, Z. Krejčík, V. Stránecký, E. Svobodová, J. Malušková, W. Gwinner, E. Honsová, A. Lodererová, R. Oberbauer, R. Zachoval, O. Viklický,
520    9_
$a The significance of borderline changes in kidney allograft biopsies is widely debated. To help resolve this, we studied differences in intrarenal gene expression patterns between early clinical and 3-month protocol biopsies, all of which had borderline histologic changes. The gene expression profiles in training set of patients by microarray analysis and data were validated in a larger cohort using RT-qPCR. There was greater expression of immunity- and inflammation-related genes in the early clinical biopsies compared to the 3-month protocol biopsies with borderline changes. In early clinically manifested borderline changes, graft deterioration within 24 months due to chronic rejection was associated with increased activation of immune, defense, and inflammatory processes. Regression modeling identified higher donor age and expression of macrophage receptor CLEC5A as risk factors for progression. In the 3-month protocol biopsies with borderline changes, graft dysfunction was associated with increased expression of fibrinogen complex transcripts. The discrimination power of fibrinogen was confirmed by cross-validation on two independent cohorts. Thus, our study highlights variations in gene expression between clinical and subclinical borderline changes despite similar histological findings. The data also support a recommendation for frequent patient monitoring, especially in those with borderline changes who received grafts from older donors.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a asymptomatické nemoci $7 D058070
650    _2
$a biopsie $7 D001706
650    _2
$a časná diagnóza $7 D042241
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a regulace genové exprese $7 D005786
650    12
$a genetické markery $7 D005819
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a rejekce štěpu $x genetika $x patologie $x patofyziologie $7 D006084
650    _2
$a lidé $7 D006801
650    _2
$a ledviny $x patologie $x patofyziologie $7 D007668
650    _2
$a transplantace ledvin $x škodlivé účinky $7 D016030
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a diagnostické techniky molekulární $7 D025202
650    _2
$a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
650    _2
$a fenotyp $7 D010641
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a validační studie $7 D023361
700    1_
$a Brabcová, Irena $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0079327
700    1_
$a Gueler, Faikah $u Department of Nephrology, Hannover Medical School, Hannover, Germany.
700    1_
$a Krejčík, Zdeněk $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
700    1_
$a Stránecký, Viktor $u Institute of Inherited Metabolic Disorders, 1st Faculty of Medicine Charles University and General Faculty Hospital, Prague, Czech Republic. $7 xx0128943
700    1_
$a Svobodová, Eva $u Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Malušková, Jana $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0159252
700    1_
$a Gwinner, Wilfried $u Department of Nephrology, Hannover Medical School, Hannover, Germany.
700    1_
$a Honsová, Eva, $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $d 1956- $7 xx0075648
700    1_
$a Lodererová, Alena $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0078780
700    1_
$a Oberbauer, Rainer $u Department of Nephrology and Dialysis, Medical University Vienna, Vienna, Austria.
700    1_
$a Zachoval, Roman, $u Department of Urology, Thomayer's Hospital, Prague, Czech Republic. $d 1967- $7 mzk2004248672
700    1_
$a Viklický, Ondřej, $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Biomedical Centre, Faculty of Medicine in Plzen, Charles University in Prague, Plzen, Czech Republic. $d 1966- $7 nlk20050170291
773    0_
$w MED00010141 $t Kidney international $x 1523-1755 $g Roč. 88, č. 4 (2015), s. 785-795
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26176825 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20191118101446 $b ABA008
999    __
$a ok $b bmc $g 1166681 $s 952997
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 88 $c 4 $d 785-795 $e 20150715 $i 1523-1755 $m Kidney international $n Kidney Int $x MED00010141
GRA    __
$a NT11227 $p MZ0
GRA    __
$a NT14102 $p MZ0
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Možnosti archivace